Brazil
  • pt
  • en
    • Search

    EDOC

    Telemedicine & Digital Health ETF

    Invest in EDOC

    Reasons to Consider EDOC

    High Growth Potential

    The global telemedicine market increased over 8% from 2022 to 2023, exceeding $94bn. Forecasts suggest the market could reach over $286bn by 2028.1

    Leveraging Artificial Intelligence

    AI could be the missing link to achieve transformative digitization in the Health Care sector. In the U.S. alone, it's estimated that AI could save as much as 10% of annual health care spending.2

    Expanding Use Cases

    Following success in diabetic monitoring, wearables are expanding into cardiovascular care. The potential market could be enormous, as an estimated 33mm people have atrial fibrillation3 and some 1.28bn adults have hypertension.4

    1Fortune Business Insights, Jul 2023
    2National Bureau of Economic Research, Jan 2023
    3Frontiers in Public Health, Jun 2023
    4World Health Organization, Mar 2023

    Key Information As of 07/26/24

    Inception Date 07/29/20
    Total Expense Ratio 0.68%
    Net Assets $44.23 million
    NAV $9.10

    ETF Summary

    The Global X Telemedicine & Digital Health ETF (EDOC) seeks to invest in companies positioned to benefit from further advances in the field of telemedicine and digital health. This includes companies involved in Telemedicine, Health Care Analytics, Connected Health Care Devices, and Administrative Digitization.

    ETF Objective

    The Global X Telemedicine & Digital Health ETF (EDOC) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Telemedicine & Digital Health Index.

    Trading Details As of 07/26/24

    Ticker EDOC
    B3 Trading Code BEDC39
    Bloomberg Index Ticker SOLEDOC
    CUSIP 37954Y285
    ISIN US37954Y2853
    Primary Exchange Nasdaq
    Shares Outstanding 4,860,000
    Number of Holdings 47
    30-Day Median Bid-Ask Spread 0.97%

    Distributions As of 07/26/24

    30-Day SEC Yield 0.40%
    Distribution Frequency Semi-Annually
     Distribution History

    ETF Prices As of 07/26/24

    NAV $9.10 Daily Change -$0.06 -0.66%
    Market Price $9.05 Daily Change -$0.07 -0.77%

    Performance History

    Premium Discount Chart
    Cumulative Returns (as of 06/28/24)
    		1 Month 6 Months YTD 12 Months 24 Months Since Inception Inception Date
    Return EDOC -2.98% -13.38% -13.39% -24.53% -23.82% -42.20% 07/29/20
    Returns (as of 07/25/24)
    		Return EDOC Return Index
    Since Inception -39.84% -38.66%
    12 Months -23.85% -23.35%
    24 Months -28.17% -27.52%
    Last 60 Trading Days 2.50% 2.66%
    Last 75 Trading Days -0.39% -0.20%
    Monthly Returns (through 07/25/24)
    		Return EDOC Return Index
    Jul 2024 4.10% 4.15%
    Jun 2024 -2.98% -2.94%
    May 2024 2.50% 2.59%
    Apr 2024 -7.32% -7.26%
    Mar 2024 -0.02% 0.06%
    Feb 2024 1.91% 1.92%
    Jan 2024 -7.79% -7.67%
    Dec 2023 13.52% 13.51%
    Nov 2023 9.42% 9.52%
    Oct 2023 -10.99% -11.00%
    Sep 2023 -11.21% -11.15%
    Aug 2023 -13.97% -13.91%
    Jul 2023 3.18% 3.21%
    Jun 2023 4.66% 4.70%
    May 2023 -5.45% -5.40%
    Apr 2023 -0.09% -0.03%
    Mar 2023 0.33% 0.40%
    Feb 2023 -6.01% -6.31%
    Jan 2023 7.01% 7.03%
    Dec 2022 -4.53% -4.47%
    Nov 2022 4.52% 4.60%
    Oct 2022 3.35% 3.84%
    Sep 2022 -7.68% -8.05%
    Aug 2022 -3.76% -3.66%
    Jul 2022 10.41% 10.44%

    Total returns take into account management, administration and fees and other costs automatically deducted from the fund's assets. Before investing, you may read the prospectus in the “FEES AND EXPENSES” section for more details.

    NAV & Index Chart

    Top Holdings As of 07/26/24

    Full Holdings (.csv)
    Net Assets (%) Ticker Name Country SEDOL Market Price ($) Shares Held Market Value ($)
    4.85 TWST TWIST BIOSCIENCE CORP United States BGKG6G7 58.08 36,908 2,143,616.64
    4.63 DOCS DOXIMITY INC-CLASS A United States BMD22Y4 28.16 72,723 2,047,879.68
    4.58 HIMS HIMS & HERS HEALTH INC United States BN46048 21.77 93,065 2,026,025.05
    4.55 PODD INSULET CORP United States B1XGNW4 193.30 10,408 2,011,866.40
    4.22 RMD RESMED INC United States 2732903 197.04 9,476 1,867,151.04
    4.16 DGX QUEST DIAGNOSTICS INC United States 2702791 145.59 12,636 1,839,675.24
    4.16 QGEN QIAGEN N.V. United States BMGBZP0 43.94 41,867 1,839,635.98
    3.99 LH LABCORP HOLDINGS INC United States BSBK800 210.90 8,367 1,764,600.30
    3.92 A AGILENT TECHNOLOGIES INC United States 2520153 137.32 12,642 1,735,999.44
    3.91 IQV IQVIA HOLDINGS INC United States BDR73G1 239.67 7,211 1,728,260.37
    3.88 TNDM TANDEM DIABETES CARE INC United States BF3W461 40.05 42,807 1,714,420.35
    3.85 ILMN ILLUMINA INC United States 2613990 120.43 14,150 1,704,084.50
    3.59 AMN AMN HEALTHCARE United States 2813552 63.26 25,131 1,589,787.06
    3.54 OSCR OSCAR HEALTH -A United States BKY83Q6 15.82 98,848 1,563,775.36
    3.29 6618 HK JD HEALTH Hong Kong BMW8R04 2.66 546,500 1,455,970.69
    3.18 EVH EVOLENT HEALTH INC - A United States BYLY8H1 23.66 59,434 1,406,208.44
    3.18 241 HK ALIBABA HEALTH Hong Kong BRXVS60 0.42 3,363,400 1,404,414.33
    3.15 MASI MASIMO CORP United States B1YWR63 108.99 12,800 1,395,072.00
    3.15 PRVA PRIVIA HEALTH GROUP INC United States BMDP209 20.46 68,023 1,391,750.58
    2.98 IRTC IRHYTHM TECHNOLOGIES INC United States BYT4ST5 88.34 14,940 1,319,799.60
    2.96 RCM R1 RCM INC United States BP2S437 13.01 100,625 1,308,628.13
    2.62 VCYT VERACYTE INC United States BFTWZY0 23.72 48,925 1,160,501.00
    2.37 TDOC TELADOC HEALTH INC United States BYQRFY1 9.37 111,763 1,047,219.31
    1.97 OMCL OMNICELL INC United States 2789523 29.31 29,733 871,474.23
    1.97 PHR PHREESIA INC United States BKF9DQ8 24.77 35,107 869,600.39
    1.82 DXCM DEXCOM INC United States B0796X4 64.00 12,604 806,656.00
    1.12 1833 HK PING AN HEALTHCA Hong Kong BDRYVB3 1.43 347,300 496,441.54
    1.04 DH DEFINITIVE HEALT United States BMGSDK2 6.03 76,509 461,349.27
    1.01 GDRX GOODRX HOLDIN-A United States BMTVQT8 8.85 50,705 448,739.25
    0.83 PACB PACIFIC BIOSCIEN United States B4N8MH9 2.14 171,355 365,842.93
    0.80 4480 JP MEDLEY INC Japan BK93ZN7 26.57 13,353 354,839.22
    0.72 LFST LIFESTANCE HEALT United States BN0TRB7 5.58 57,038 318,272.04
    0.71 FLGT FULGENT GENETICS INC United States BYQBFQ5 23.66 13,239 313,234.74
    0.68 COP GR COMPUGROUP MEDIC Germany BMY7CH1 16.99 17,621 299,374.31
    0.67 4483 JP JMDC INC Japan BK7C5Q9 21.64 13,608 294,433.03
    0.47 DCGO DOCGO INC United States BKP4P23 3.74 55,702 208,325.48
    0.39 228760 KS GENOMICTREE INC Republic Of Korea BYNNYF6 15.08 11,347 171,148.77
    0.37 TALK TALKSPACE INC United States BP7L970 2.04 80,248 163,705.92
    0.33 LFMD LIFEMD INC United States BMXDBQ2 7.03 20,519 144,248.57
    0.30 SENS SENSEONICS HOLDINGS INC United States BYQNYR5 0.43 306,535 132,944.23
    0.09 GRAL GRAIL INC United States BSLSSX7 16.32 2,356 38,441.76
    0.04 CASH United States 1.00 15,707 15,706.67
    0.00 AUSTRALIAN DOLLAR United States 0.66 837 548.38
    0.00 EURO United States 1.08 1 1.04
    0.00 HONG KONG DOLLAR United States 0.13 4 0.51
    0.00 TAIWAN DOLLAR United States 0.03 1 0.03
    -0.02 OTHER PAYABLE & RECEIVABLES United States 1.00 -7,630 -7,629.96
    Holdings are subject to change. "Cash" denotes U.S. dollars.

    Sector Breakdown As of 06/30/24

    Sector Weight (%)
    Health Care 88.5
    Consumer Staples 7.8
    Financials 3.6
    Other/Cash 0.1

    Source: AltaVista Research, LLC

    Country Breakdown As of 06/30/24

    Country Weight (%)
    United States 84.7
    China 4.8
    Netherlands 4.2
    Hong Kong 3.3
    Japan 1.4
    Germany 1.1
    South Korea 0.5

    Source: AltaVista Research, LLC

    ETF Characteristics As of 07/25/24

    Return on Equity 3.70%
    Weighted Avg. Market Cap 10,871 M
    2023 2024
    Price-to-earnings 94.91 67.80
    Price-to-book value 2.55 2.47

    Source: AltaVista Research, LLC

    ETF Risk Stats As of 06/30/24

    Versus Beta
    S&P 500 1.06
    MSCI EAFE 1.14
    MSCI Emg. Mkts 0.91
    Standard Deviation 24.20%

    Source: AltaVista Research, LLC

    ETF Documents

    TERMS OF USE

    Global X Brasil Gestora de Investimentos Ltda. (“Global X Brasil”) is an asset manager authorized by the Brazilian Securities and Exchange Commission (“CVM”), constituted in the form of CVM Resolution No. 21/2021. Investing involves risks. The material on this site is for informational purposes only and does not constitute investment advice, recommendation, offer or solicitation to buy or sell any securities, funds, or strategies to any person in any jurisdiction in which an offer, solicitation, purchase, or sale would be illegal under the securities laws of such jurisdiction. Opinions expressed here are subject to change without notice. Reliance upon the information contained in this material is at the sole discretion of the reader. No securities regulator has confirmed the accuracy of any information contained herein. Access to the information on this site or the use of the services or information provided herein is prohibited by any person or entity in any jurisdiction or country where such distribution or use is contrary to local law, rules, or regulation. Investment in index funds (ETFs) involves risks, including detachment from the benchmark index and related to the liquidity of shares in the secondary market. Investment funds managed by Global X Brasil use strategies that can result in significant equity losses for their quota holders. Global X Brasil, its partners and employees are exempt of responsibility for any damages resulting directly or indirectly from the use of the information contained on this website.

    FOR EVALUATION OF THE PERFORMANCE OF AN INVESTMENT FUND, IT IS RECOMMENDED THE ANALYSIS OF AT LEAST 12 (TWELVE) MONTHS. INVESTMENT FUNDS DO NOT HAVE A GUARANTEE FROM THE ADMINISTRATOR, THE MANAGER, ANY INSURANCE MECHANISM OR CREDIT GUARANTEE FUND – FGC. INVESTMENTS IN FINANCIAL AND CAPITAL MARKETS ARE SUBJECT TO RISKS OF LOSS GREATER THAN THE TOTAL VALUE OF INVESTED CAPITAL. PAST PROFITABILITY DOES NOT REPRESENT A GUARANTEE OF FUTURE PROFITABILITY THE PROFITABILITY DISCLOSED IS NOT NET OF TAXES. READ THE PROSPECTUS, THE FORM OF COMPLEMENTARY INFORMATION, SHEET OF ESSENTIAL INFORMATION AND THE REGULATION BEFORE INVESTING. DESCRIPTION OF THE ANBIMA TYPE AVAILABLE IN THE FORM OF COMPLEMENTARY INFORMATION.

    Back to Top